AAAAAA
Results:
1-12
|
Results: 12
Authors:
De Baere, E
Dixon, MJ
Small, KW
Jabs, EW
Leroy, BP
Devriendt, K
Gillerot, Y
Mortier, G
Meire, F
Van Maldergem, L
Courtens, W
Hjalgrim, H
Huang, S
Liebaers, I
Van Regemorter, N
Touraine, P
Praphanphoj, V
Verloes, A
Udar, N
Yellore, V
Chalukya, M
Yelchits, S
De Paepe, A
Kuttenn, F
Fellous, M
Veitia, R
Messiaen, L
Citation: E. De Baere et al., Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation, HUM MOL GEN, 10(15), 2001, pp. 1591-1600
Authors:
Touraine, P
Plu-Bureau, G
Beressi, N
Decq, P
Thalabard, JC
Kuttenn, F
Citation: P. Touraine et al., Resumption of luteinizing hormone pulsatility and hypogonadotropic hypogonadism after endoscopic ventriculocisternostomy in a hydrocephalic patient, FERT STERIL, 76(2), 2001, pp. 390-393
Authors:
Llovera, M
Pichard, C
Bernichtein, S
Jeay, S
Touraine, P
Kelly, PA
Goffin, V
Citation: M. Llovera et al., Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation, ONCOGENE, 19(41), 2000, pp. 4695-4705
Authors:
Llovera, M
Touraine, P
Kelly, PA
Goffin, V
Citation: M. Llovera et al., Involvement of prolactin in breast cancer: redefining the molecular targets, EXP GERONT, 35(1), 2000, pp. 41-51
Authors:
Vigouroux, C
Magre, J
Vantyghem, MC
Bourut, C
Lascols, O
Shackleton, S
Lloyd, DJ
Guerci, B
Padova, G
Valensi, P
Grimaldi, A
Piquemal, R
Touraine, P
Trembath, RC
Capeau, J
Citation: C. Vigouroux et al., Lamin A/C gene - Sex-determined expression of mutations in dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenitaland acquired generalized lipoatrophy, DIABETES, 49(11), 2000, pp. 1958-1962
Authors:
Goffin, V
Binart, N
Clement-Lacroix, P
Bouchard, B
Bole-Feysot, C
Edery, M
Lucas, BK
Touraine, P
Pezet, A
Maaskant, R
Pichard, C
Helloco, C
Baran, N
Favre, H
Bernichtein, S
Allamando, A
Ormandy, C
Kelly, PA
Citation: V. Goffin et al., From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice models, GENET A-BIO, 15(3-5), 1999, pp. 189-201
Authors:
Bry-Gauillard, H
Touraine, P
Mamzer-Bruneel, MF
Simoes-Vaz, A
Kuttenn, F
Legendre, C
Citation: H. Bry-gauillard et al., Complete regression of a major hyperprolactinaemia after renal transplantation, NEPH DIAL T, 14(2), 1999, pp. 466-468
Authors:
Touraine, P
Beau, I
Gougeon, A
Meduri, G
Desroches, A
Pichard, C
Detoeuf, M
Paniel, B
Prieur, M
Zorn, JR
Milgrom, E
Kuttenn, F
Misrahi, M
Citation: P. Touraine et al., New natural inactivating mutations of the follicle-stimulating hormone receptor: Correlations between receptor function and phenotype, MOL ENDOCR, 13(11), 1999, pp. 1844-1854
Authors:
Misrahi, M
Beau, I
Meduri, G
Touraine, P
Bouvattier, C
Bougneres, P
Kuttenn, F
Milgrom, E
Citation: M. Misrahi et al., Clinical manifestations of germinal mutations inactivating the gonadotropin receptors, M S-MED SCI, 15(2), 1999, pp. 219-224
Authors:
Goffin, V
Touraine, P
Pichard, C
Bernichtein, S
Kelly, PA
Citation: V. Goffin et al., Should prolactin be reconsidered as a therapeutic target in human breast cancer?, MOL C ENDOC, 151(1-2), 1999, pp. 79-87
Authors:
Plu-Bureau, G
Touraine, P
Marvais-Jarvis, P
Citation: G. Plu-bureau et al., Interactions between estradiol and progesterone in normal breast - Implications for mammary carcinogenesis, CONT ENDOC, 11, 1999, pp. 21-37
Authors:
Touraine, P
Deneux, C
Plu-Bureau, G
Mauvais-Jarvis, P
Kuttenn, F
Citation: P. Touraine et al., Hormonal replacement therapy in menopausal women with a history of hyperprolactinemia, J ENDOC INV, 21(11), 1998, pp. 732-736
Risultati:
1-12
|